UOC Ematologia, Ospedale S.Eugenio
Welcome,         Profile    Billing    Logout  
 5 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Niscola, Pasquale
Phoenix, NCT05924100 / 2021-001538-20: Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD

Recruiting
2
22
Europe
Luspatercept Injection [Reblozyl]
Associazione Qol-one, Celgene BMS
Myelodysplastic Syndromes, Del(5Q), Anemia, Transfusion-dependent Anemia
12/24
12/29
IDIOME-STUDY, NCT03503409: IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome

Active, not recruiting
2
68
Europe
AG-120
Groupe Francophone des Myelodysplasies
Myelodysplastic Syndromes, Acute Myeloid Leukemia
04/25
04/25
NCT04460950: Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Recruiting
N/A
237
Europe
Gruppo Italiano Malattie EMatologiche dell'Adulto
Acute Myeloid Leukemia, Familial Acute Myeloid Leukemia, Myelodysplastic Syndromes
03/25
03/25
FISiM-NGS-MDS, NCT04212390: Personalized Medicine Program on Myelodysplastic Syndromes: Characterization of the Patient's Genome for Clinical Decision Making and Systematic Collection of Real World Data to Improve Quality of Health Care

Recruiting
N/A
1000
Europe
Fondazione Italiana Sindromi Mielodisplastiche-ETS
MDS (Myelodysplastic Syndrome)
03/24
03/25
CLARITY, NCT03190525: Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma

Recruiting
N/A
520
Europe
Quality of life questionnaires
Gruppo Italiano Malattie EMatologiche dell'Adulto
Multiple Myeloma
12/24
12/24

Download Options